Results 111 to 120 of about 30,626 (259)

“Different strokes for different folks” [PDF]

, 2012
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90351/1/1924_ftp ...
Adam, Alvernia, Boelaert, Calfee, Christopher Douglas, Eric Wallace, Kontoyiannis, Moskowitz, Nasia Safdar, Numa, Reed, Robert M. Centor, Roden, Sanjay Saint, Schmitt, Thajeb, Tversky, van Burik   +17 more
core   +1 more source

Cutaneous mucormycosis in advanced HIV disease

Brazilian Journal of Infectious Diseases, 2016
Angionvasive mucormycosis is an emerging fungal disease known to affect mainly diabetics or subjects with profound neutropenia. Infection usually occurs through the inhalation route, but cutaneous inoculation may occur after trauma or burns.
José Moreira, Felipe Ridolfi, Rodrigo Almeida-Paes, Andrea Varon, Cristiane C. Lamas   +4 more
doaj   +1 more source

Mortality, morbidity and sequelae of COVID-associated mucormycosis; 18 months follow up study

, 2023
Nithya Venkataramani, Ravi Sachidananda, Sonali Muralidhar, Sushma Krishna, A. V. Pradeep, Suraksha Rao, Basanth Kumar, Saikiran Shankarnarayan, N. Karthik, Rajesh K. Nagarajaiah, Sunil S, Srividya Rao Vasista   +11 more
openalex   +2 more sources

Comparative study on the antifungal activity of hydroalcoholic extract of Iranian Propolis and Royal jelly against Rhizopus oryzae [PDF]

, 2015
Introduction: Mucormycosis is an opportunistic fungal infection. Rhizopus oryzae is major cause of mucormycosis in humans. This disease is the most common form of the acute fungal infection with rapid progress.
Khabbazi, Hamideh., Kheiri, Soleiman., Moghim, Hassan., Shahinfard, Najmeh., Taghipoor, Simin.   +4 more
core   +1 more source

Treatment of Aspergillosis. [PDF]

, 2018
Infections caused by Aspergillus spp. remain associated with high morbidity and mortality. While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive aspergillosis (IA) in those patients most at risk for infection ...
Hoenigl, Martin, Jenks, Jeffrey D
core   +1 more source

Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study

Journal of Family Medicine and Primary Care
Introduction: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited.
Akkilagunta Sujiv, N. R. Aiswarya Lakshmi, Pradeep Ramrao Deshmukh, Jaya Prasad Tripathy, Mubashshera F. Khan, Victoria Thomas   +5 more
doaj   +1 more source

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child [PDF]

, 2018
Voriconazole is increasingly used as a first-line agent for empirical antifungal therapy of prolonged febrile neutropenia in paediatric cancer patients. We describe the case of a 9-year-old patient with stage IV Burkitt lymphoma, who developed pulmonary ...
Aebi, Christoph, Aebischer, Carmen, Ammann, Roland, Gugger, Mathias, Jaton, Katia, Ritz, Nicole, Schmid, Ralph   +6 more
core  

Rehabilitation of patient using a patient-specific implant with bar-retained maxillary obturator and orbital prosthesis postoperated rhino-orbital mucormycosis

, 2023
Vaibhav Jain, Shakeel Nagori
openalex   +1 more source

Emergence of mucormycosis in post-COVID infections in tertiary care hospital Warangal

Journal of Dr. NTR University of Health Sciences
Introduction: Mucormycosis is an emerging fungal infection associated with high mortality, especially in post-COVID state. Mucormycosis, though fungal spores ubiquitous in the environment, is a clinical disease that occurs in immunocompromised conditions.
Goteti V. Padmaja, Shanigarapu R. Kumar
doaj   +1 more source

Rare cause of lower gastrointestinal bleed

Journal of Digestive Endoscopy, 2017
Gastrointestinal (GI) mucormycosis commonly affects adults with neutropenia or other immunocompromising conditions. GI mucormycosis is uncommon but has high mortality rate.
Mukesh Nasa, Mahesh Gupta, Randhir Sud, Lipika Lipi   +3 more
doaj   +1 more source